QS Investors’s Ironwood Pharmaceuticals IRWD Stock Holding History

QS Investors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,800	Closed	-$50K	–	1361
2020 Q2	$50K	Sell	4,800 -8,300	-63%	-$84.9K	﹤0.01%	1454
2020 Q1	$133K	Buy	+13,100	New	+$154K	﹤0.01%	1182
2018 Q4	–	Sell	-3,463	Closed	-$54K	–	1911
2018 Q3	$54K	Hold	3,463	–	–	﹤0.01%	1481
2018 Q2	$55K	Hold	3,463	–	–	﹤0.01%	1500
2018 Q1	$45K	Hold	3,463	–	–	﹤0.01%	1489
2017 Q4	$43K	Hold	3,463	–	–	﹤0.01%	1505
2017 Q3	$46K	Hold	3,463	–	–	﹤0.01%	1537
2017 Q2	$55K	Sell	3,463 -49	-1%	-$712	﹤0.01%	1492
2017 Q1	$50K	Buy	3,512 +3,463	+7,067%	+$47.3K	﹤0.01%	1515
2016 Q4	$1K	Buy	+49	New	+$619	﹤0.01%	1635
2016 Q1	–	Sell	-30	Closed	-$1K	–	2016
2015 Q4	$1K	Buy	+30	New	+$290	﹤0.01%	1679

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

QS Investors's IRWD Position: Q3 2020 in Review

QS Investors sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 4,800 shares — an estimated $50K sold.

QS Investors first reported a position in IRWD in Q4 2015 and held it in 11 quarters. The position peaked at $133K in Q1 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

QS Investors reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
QS Investors sold 4,800 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $50K.
QS Investors first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 11 quarters.
QS Investors's Ironwood Pharmaceuticals position peaked at $133K in Q1 2020.
190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.